Over the next several weeks, TomoTherapy and Hi-Art will negotiate a definitive purchase agreement. The transaction is expected to close in the fourth quarter of 2008, at which time the current distribution agreement will cease.
Fred Robertson, CEO of TomoTherapy, said: “As TomoTherapy grows, we continue to assess how we can best serve our customers in all markets. This move in Japan reflects our commitment to our current and future Japanese customers.”